Future Prospects in the Diagnosis and Management of Localized Prostate Cancer
Prostate cancer (PCa) is the commonest visceral cancer in men worldwide. Introduction of serum PSA as a highly specific biomarker for prostatic diseases has led to a dramatic increase in the diagnosis of early stage PCa in last decades. Guidelines underline that benefits as well as risks and squeals...
Saved in:
Main Authors: | Ahmet Tefekli, Murat Tunc |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1155/2013/347263 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CHROMOGRANIN-A IN THE DIAGNOSIS OF PROSTATE CANCER
by: A. V. Sivkov, et al.
Published: (2015-04-01) -
Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer
by: Yuxuan Chen, et al.
Published: (2025-01-01) -
Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia
by: Wei Jin, et al.
Published: (2020-01-01) -
Focal Laser Ablation of Prostate Cancer: Definition, Needs, and Future
by: Pierre Colin, et al.
Published: (2012-01-01) -
Photodynamic therapy for the precise treatment of localized prostate cancer
by: Youcheng Xu, et al.
Published: (2025-02-01)